Brainscape's Knowledge GenomeTM

Browse over 1 million classes created by top students, professors, publishers, and experts.


See full index

Clinical Psychology > Psychosis & Schizophrenia > Flashcards

Psychosis & Schizophrenia Flashcards

You may prefer our related Brainscape-certified flashcards:
Psychology 101 flashcards GRE® Psychology flashcards AP® Psychology flashcards
1
Q

Psychoses/Schizophrenia Features

A

MAIN FEATURES
RISK/PROTECTIVE FEATURES
- BIOLOGICAL (GENETIC/BIOCHEM/NEURO)
- PSYCHO-SOCIAL (DEPRIVATION/FAMILY ISSUES/LONG-TERM STRESS)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

P/S: Media Representation

A
  • psychosis/psychotic = anti-social/schizophrenia = “split-personality”; WRONG/MISLEADING/JUDGEMENTAL/DAMAGING misconceptions!; only lead to stigma/social isolation
  • even “positive” media representation still glorifies/makes it into an egoistical tragedy (ie. ‘A Beautiful Mind’)
  • psychosis = loss of “shared” reality
  • schizophrenia = split real/imaged mind
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

P/S: Statistics

A
  • 8% of all homicide convictions in England/Wales during 18 months contacted mental healthy services in previous year
  • 25% of these diagnosed w/schizophrenia; most had personality disorder/alcohol or drug misuse
  • schizophrenics no more prone to criminal violence than general public
  • 10% of schizophrenics commit suicide
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

PF: Main Features

A 
- loss of socially perceived/shared awareness of reality due to:
SCHIZOPHRENIA (?)
DRUG MISUSE
SEVERE DEPRESSION
NEUROLOGICAL INJURY
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

SF: Main Features

A
  • delusional beliefs (aka. misinterpretation of reality); ie. believing neighbour is mind-controlling them/people on TV are sending special messages/thoughts can be broadcasted
  • hallucinations (ie. hearing voices commenting/arguing/directing; often terrifying)
  • withdrawal states (ie. avolition = loss of energy/absence of daily interest)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Schizophrenia Diagnosis

A
  • SYMPTOM GROUPS (POSITIVE/NEGATIVE)
  • MAIN FORMS
  • ICD-10 DIAGNOSTIC CRITERIA
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

SD: Symptom Groups (Positive)

A
  • “excess cognition”
  • PICCHIONI & MURRAY (2007); most common include:
  • insight lack
  • auditory hallucinations = 97%
  • delusional reference = 74%
  • suspiciousness = 66%
  • flatness of effect = 66%
  • thought alienation = 52%
  • out-loud thoughts = 50%
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

SD: Symptom Groups (Negative)

A
  • “deficits in behaviour”

- IE. avolition/alogia (speech poverty)/anhedonia/flat effect (fake outward expression)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

SD: Main Forms

A

DISORGANISED:
- speech content disordered; bizarre associations
- disorganised behaviour incongruent to social cues
CATATONIC:
- apathy/withdrawal/immobility w/islands of excitement/agitation; experience sometimes recalled
PARANOID:
- (persecutory) delusion prominent (ie. reference = random convo snippets refer to them); hallucinations; 1/100 across culture rate

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

SD: ISD-10 Diagnostic Criteria

A

+/=1 MOST OF MONTH:
- thought echo/insertion/withdrawal/broadcast
- control/perception delusions regarding body/actions/sensations
- hallucinatory voices w/running commentary/patient discussion OR sourced in patients body
- persistent bizarre/culturally inappropriate delusions
+/=2 MOST OF MONTH:
- daily hallucinations + delusions
- incoherent/irrelevant speech
- catatonic behaviour (ie. stupor/posturing)
- negative symptoms (ie. apathy/incongruous mood)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

SF: Biological Factors (Genetic)

A
  • genetic risk on range of disorders related via shared neuro-chemical underpinnings
  • GOTTESMANN & SHIELDS (1972); twin studies concordance; MZ = 42%; DZ = 9%; re-analysis showed negative symps more linked than positive; interaction w/environment leads to variance
  • HESTON (1966); adoptee studies; greater schizophrenia risk w/diagnosed schizophrenic birth mothers even if kids raised in alternative environment
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

SF: Biological Factors (Genetic) Examples

A
  • PICCHIONI & MURRAY (2007); schizophrenia as multifactorial; greatest risk = positive family history; general pop lifetime risk = <1%; 6-5% in first relatives; 40% in MZ twins; many common, small-effect risk genes exist; interaction w/environment past critical threshold may trigger development
  • CARDNO et al (2002); twins (one diagnosed schizophrenic/schizoaffective manic); 47 MZ; 89 DZ SS; statsig genetic correlations of syndromes; common/specific genetic contribution; relaxed diagnostic hierarchies showed overlap in genes w/RDC (research diagnostic criteria) and syndromes
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

SF: Biological Factors (Biochemical)

A
  • symptoms triggered by chemical imbalances due to possible genetic risk/injury/drug intake (or combo)
  • ie. Parkinson’s; control/initiation issue; related w/brain area linked to dopamine activity; treatment risks hallucinations
  • schizophrenia = excess dopamine; symptoms lesson via psychotropic meds inhibiting dopamine
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

SF: Biological Factors (Neurochemical)

A
  • YOON et al (2013); schizophrenic brain systems; excess activity in substantia nigra; decreased activity in prefrontal cortex; diminished functional connectivity between them suggests un-synced communication; high connectivity between substantia nigra + striatum = high schizophrenic psychosis
  • HADDARD et al (2016); chlorpromazine (antipsych med); induced calmness w/o sedation prior to surgery so psychiatry link; controversial work of doctors treating maniacs/schizophrenics w/it; effective results
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

PF: Biological Factors (Biochemical)

A
  • MURRAY et al (2017); cannabis as paranoia cause; prevented cases via cannabis illegality= 8-24% (country dependant; opposite USA public policy; legalisation = increased consumption/potency
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

SF: Psycho-Social Factors (Deprivation)

A
  • highest likelihood in low socio-economic groups; poor housing/low income/overcrowding/homelessness/environmental hazards/uncertainty/lack of opportunities)
17
Q

SF: Psycho-Social Factors (Long-Term Stress)

A
  • more common w/less control over decisions/processes governing life
  • triggered via stressful life events (ie. bereavement/job loss/divorce/relationship end/significant transitions)
  • work/education act as buffers
18
Q

SF: Psycho-Social Factors (Family Issues)

A
  • “expressed emotion”; INSUFFICIENT for independent onset, but likely relapse trigger; occurs prior
  • reactive to deterioration manifested by newly developing psychotic disorder rather than family traits
  • can maintain schizophrenia (ie. critical comments (“… see, she’s always like that…”)
  • 10% = low EE household relapse
  • 58% = high EE household relapse
19
Q

SF: Psycho-Social Factors (Long-Term Stress) Example

A
  • PICCHIONI & MURRAY (2007); 5% South London black men schizophrenia link; no biochemical/gene/drug risk; source found in social stress of racism
  • high schizophrenia rates in immigrant kids; not reflected in kids of home country; environmental/social factors implicated; small immigrant population = increased schizophrenia risk
20
Q

S-M/PM: Genetically/Neuro/Socio-developmental Continuum (Example)

A
  • MURRAY et al (2017); common small-effect genes shared w/autism/learning disability; neuro-developmental genetic risk continuum; schizophrenic polygenic risk scores reflect polygenic loading; genetic variants associated w/schizophrenia impact on brain/cognitive development
  • risk genes influencing upstream factors render midbrain dopamine neurons vulnerable to dysregulation via socio-developmental risk factors; downstream influencers amplify dysregulation effect
21
Q

S-M/PM: Developmental Risk Factor Model

A
  • MURRAY et al (2017); neuro-developmental factors interact w/adverse social/drug risk factors; lead to neuro/social cognition/neural network deficits
  • increase scholastic difficulty/a-sociality/isolation risk; rebranded as primary negative symptoms
  • increased deviance drug abuse/victimisation exposure risk = dysregulated dopamine release; salience assigned to perceptions
  • social adversity exposure biases cognitive schema to excessively interpret experiences via paranoia
    VICIOUS CYCLE:
  • stress = increased dopamine dysregulation = stress via psychotic experiences = further dopamine release = hardwired psychotic interpretation
22
Q

Schizophrenia Medical/Psychological Models

A

DEVELOPMENTAL RISK FACTOR MODEL

GENETICALLY/NEURO/SOCIO-DEVELOPMENTAL CONTINUUM

23
Q

S-M/PM: Genetically/Neuro/Socio-developmental Continuum

A
  • genetic risk normally distributed; polygenetic risk may be manageable w/precision medicine
  • “probable” viral infection risk (ie. in-utero)
  • drug intake risks brain development
  • social disadvantage/family environment/stress history risk
  • ALL MIXING = NOT disease entity but bio/psycho/social condition w/influential factors
24
Q

Psychosis/Schizophrenia Treatments

A 
MEDICAL SERVICES
SOCIO-BEHAVIOURAL 
- CBT
- FAMILY THERAPY
- "CONTINUUM OF EXPERIENCE"
25
Q

PT: Medical Services

A
  • historical institutions of “no treatment”
  • 1930-50s; ineffective/damaging “treatments” (ie. psychosurgery/electro-convulsive therapy (ECT))
  • neuroleptics in 1950s; block dopamine via positive symptom reduction; “calming”; BUT negative symptoms untouched/frightening parkinsonism effects = discontinuation/resistance
  • FIRST/SECOND GENERATION PSYCHOTICS
26
Q

PT-MS: First Generation Psychotics & Side Effects

A
  • ANTICHOLINERGIC: blurred vision/dry mouth/urinary retention/weight gain/sexual dysfunction/cardiotoxicity
  • EXTRAPYRAMDIAL: pseudoparkinsonism/akathisia (inability to be still)/dystonia (twisting muscles)/reduced seizure threshold/postural hypotension/hyperprolactinaemia (increased stress hormone production)
27
Q

PT-MS: Second Generation Psychotics & Side Effects

A
  • OLANZAPINE: weight gain/sedation/glucose intolerance/hypotension
  • RISPERIDONE: hyperprolactinaemia/hypotension/sexual dystfunction/extrapyramidal side effects (high dosage)
  • AMISULPIRIDE: hyperprolactinaemia/insomnia/extrapyramidal side effects
  • QUETIAPINE: hypotension/dyspepsia (indigestion)/drowsiness
  • CLOZAPINE: hypersalivation/constipation/reduced seizure threshold/hypotension/tachycardia (increased heart rate)/pyrexia (increased temp)/weight gain/glucose intolerance/nocturnal enuresis (involuntary nightly urination)
28
Q

PT-SB: Family Therapy

A
  • risk of “revolving door” management (aka. being sent from helpline to helpline to helpline…)
  • FAMILY THERAPY (FT); prevents relapse; educative/collaborative/constructive method of reducing confrontational EE
  • reduced stress = reduced relapse
  • FALLOON et al (1982); 18 in FT/control; EE lowered = FT; 2 FT relapsed; 9 control relapsed
29
Q

PT-MS: Rare Serious Clozapine Side Effects

A
  • neutropenia (93%); low white blood cells
  • agranulocytosis (0.8%); extremely low white blood cells
  • thromboembolism; blood clots in veins
  • cardiomyopathy; heart muscle disease (tenses)
  • myocarditis; heart muscle disease (reduces pump ability)
  • aspiration pneumonia; food/saliva/liquid/vomit breathed into lung airway
30
Q

PT-SB: Family Therapy (Process)

A
  • changing family behaviour during episode
  • speaking normally/slowly/clearly (ie. “let’s sit down and talk”)
  • obvious observational statements (ie. “you’re angry/confused/afraid; please tell me why”)
  • avoid patronising/authoritative speech (ie. “you’re always such a child/you’ll do as I say”)
  • avoid intense physical contact (ie. standing over/close to them; too much emotion on your part doesn’t help)
  • avoid shouting/criticism; if you’re being ignore, other “voices” are likely being louder
31
Q

PT-SB: “Continuum of Experience”

A
  • ROMME et al (1993); 700 people responded on TV programme; 400 heard “voices”; 350 struggled to cope; 100 coped well
  • differences of “voices” included: positive messages/less commanding/selective listening/communication w/others
32
Q

PT-SB: CBT

A
  • self-monitoring for medication use
  • noticing symptoms= assessing optimum support
  • investigates belief content/voice source; ie: paranoia/persecution in gay man from orthodox religious background
  • modifying belief strength (ie. asking for physical evidence)
  • managing/answering “voices” (ie. if not expelled, can be manipulated into positive reminders of chores, etc.)
33
Q

ST-SB: CBT (Example)

A
  • LANCET (2014); CBT as effective alternative to antipsychotic drugs (high discontinuation rate due to side effects/lack of effect); schizophrenics assigned CBT and drugs or drugs alone; mean positive/negative symptoms constantly lower in CBT + drugs group; statsig results showed CBT + drug combo much better than drugs alone.
34
Q

SUMMARY

A
  • multiple potential schizophrenia causes
  • schizophrenia probably group of conditions sharing some outward symptoms
  • experience/support required for understanding/coping of client/relatives via family therapy/CBT
  • medical treatments must be developed further w/less side effects
  • interventions should be earlier/better targeted at reducing initial distress, improving outcomes
  • more long-term social solutions required (ie. equality of opportunity/human rights preservation)

Clinical Psychology (11 decks)

Brainscape helps you reach your goals faster, through stronger study habits.
© 2024 Bold Learning Solutions. Terms and Conditions